1.55
price up icon2.65%   0.04
after-market Handel nachbörslich: 1.60 0.05 +3.23%
loading
Schlusskurs vom Vortag:
$1.51
Offen:
$1.63
24-Stunden-Volumen:
284.78K
Relative Volume:
0.70
Marktkapitalisierung:
$58.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.27%
1M Leistung:
+4.73%
6M Leistung:
-29.86%
1J Leistung:
-76.34%
1-Tages-Spanne:
Value
$1.51
$1.6494
1-Wochen-Bereich:
Value
$1.40
$1.6494
52-Wochen-Spanne:
Value
$1.23
$8.1747

Metagenomi Inc Stock (MGX) Company Profile

Name
Firmenname
Metagenomi Inc
Name
Telefon
(510) 871-4880
Name
Adresse
5959 HORTON STREET, EMERYVILLE
Name
Mitarbeiter
202
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MGX's Discussions on Twitter

Vergleichen Sie MGX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MGX
Metagenomi Inc
1.55 58.69M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
439.37 128.45B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.63 65.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
560.90 40.09B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.19 35.67B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
233.25 27.44B 3.81B -644.79M -669.77M -6.24

Metagenomi Inc Stock (MGX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-07 Eingeleitet H.C. Wainwright Buy
2024-05-02 Herabstufung JP Morgan Overweight → Neutral
2024-03-05 Eingeleitet BMO Capital Markets Outperform
2024-03-05 Eingeleitet Chardan Capital Markets Buy
2024-03-05 Eingeleitet JP Morgan Overweight
2024-03-05 Eingeleitet Jefferies Buy
2024-03-05 Eingeleitet TD Cowen Outperform
2024-03-05 Eingeleitet Wells Fargo Overweight
Alle ansehen

Metagenomi Inc Aktie (MGX) Neueste Nachrichten

pulisher
May 12, 2025

Metagenomi (MGX) and Its Competitors Head-To-Head Review - Defense World

May 12, 2025
pulisher
May 11, 2025

Metagenomi (MGX) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

Metagenomi, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsMGX - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Metagenomi, Inc. (MGX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire

May 09, 2025
pulisher
May 06, 2025

Wells Fargo & Company MN Increases Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 06, 2025
pulisher
May 04, 2025

Renaissance Technologies LLC Has $555,000 Stock Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 04, 2025
pulisher
May 04, 2025

JPMorgan Chase & Co. Acquires 65,020 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 04, 2025
pulisher
May 02, 2025

Metagenomi Inc [MGX] stock for 1,744 USD was sold by Wein Matthew - knoxdaily.com

May 02, 2025
pulisher
May 02, 2025

Metagenomi Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Market Update: Metagenomi Inc (MGX) Sees Negative Movement, Closing at 1.49 - DWinneX

May 02, 2025
pulisher
May 02, 2025

Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 01, 2025

Metagenomi Inc (NASDAQ: MGX)’s -10.37-Percent Loss Of This Past Week Taught Us Something New - Marketing Sentinel

May 01, 2025
pulisher
May 01, 2025

Geode Capital Management LLC Has $2.12 Million Stock Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

May 01, 2025
pulisher
Apr 29, 2025

Metagenomi, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MGX - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 25, 2025

Levi & Korsinsky Notifies Shareholders of Metagenomi, Inc.(MGX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

Metagenomi (MGX) versus Its Competitors Critical Analysis - Defense World

Apr 24, 2025
pulisher
Apr 18, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Apr 18, 2025
pulisher
Apr 16, 2025

Corebridge Financial Inc. Grows Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Apr 16, 2025
pulisher
Apr 14, 2025

Metagenomi, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Metagenomi, Inc. - marketscreener.com

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Acquires New Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Prudential Financial Inc. - Defense World

Apr 12, 2025
pulisher
Apr 10, 2025

ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 08, 2025

Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st

Apr 08, 2025
pulisher
Apr 08, 2025

Can you still get a good price for Metagenomi Inc (MGX) Shares at this point? - uspostnews.com

Apr 08, 2025
pulisher
Apr 08, 2025

Levi & Korsinsky Reminds Shareholders of an Investigation into Metagenomi, Inc. (MGX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 07, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi Lawsuit – MGX - ACCESS Newswire

Apr 07, 2025

Finanzdaten der Metagenomi Inc-Aktie (MGX)

Es liegen keine Finanzdaten für Metagenomi Inc (MGX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.75
price up icon 4.10%
$19.93
price up icon 2.94%
$33.35
price up icon 0.60%
$25.26
price up icon 5.43%
$97.27
price up icon 4.85%
biotechnology ONC
$233.25
price up icon 0.54%
Kapitalisierung:     |  Volumen (24h):